An interview with Tomoaki Kato, MD, Chief of Abdominal Organ Transplant and Hepatobiliary Surgery, about the current and future state of liver transplantation.
In a rare procedure involving four patients, a surgical team at NewYork-Presbyterian/Columbia completed a first-of-its-kind transplant in which a recipient got a new liver from a living donor, and their original liver was split to help two people.
Xenotransplantation is inching closer to clinical reality at Columbia, where decades of work in immune tolerance are converging to make lifesaving pig-to-human organ transplants possible.
When a West Point graduate’s wife faced a rare, life-threatening cancer, it was a fellow alum—now a pioneering liver surgeon at Columbia—who stepped in to save her life.
Dr. Michel Sadelain, a pioneer of CAR T-cell therapy, is leading Columbia’s new initiative to expand the use of genetically engineered “living drugs” beyond cancer and into fields like autoimmunity and organ transplantation.
Groundbreaking research at Columbia is bringing the field of transplantation closer to eliminating lifelong immunosuppression, transforming the future for patients.
